Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2000
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127351 Method for the administration of amifostine and related compounds
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6127346 For the treatment of viruses
10/03/2000US6127336 Antibacterial and antifungal peptide
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127332 Muteins of IFN-β
10/03/2000US6127169 Non-agglutinating β-galactoside binding protein and its encoding nucleic acid
10/03/2000US6127151 Antigenic preparations and the isolation of such preparations
10/03/2000US6127147 Sensor histidine kinase of Staphylococcus Aureus
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6126944 Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus
10/03/2000US6126938 Administering two identical or different products each containing inducing agent for the immune response, selected from the antigen and, if the antigen is protein in nature, an expression cassette capable of expressing the antigen
10/03/2000US6126937 Clpl polypeptides, polynucleotides encoding clpl polypeptides and methods for producing such polypeptides by recombinant techniques.
10/03/2000CA2079171C Cyclohexapeptidyl propanolamine compounds
09/2000
09/30/2000CA2267481A1 Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
09/28/2000WO2000057186A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056894A1 Fungal beta-tubulin genes
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056748A1 Xylo-lna analogues
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056736A2 Use of non-nucleoside reverse transcriptase inhibitor (mni) for the treatment of hiv infection
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/28/2000WO2000056724A1 Oxazole and thiazole combinatorial libraries
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056366A1 Gel-microemulsion formulations
09/28/2000WO2000056365A1 Use of trehalose for stabilising a liquid vaccine
09/28/2000WO2000056362A2 Polycationic carbohydrates as immunostimulants in vaccines
09/28/2000WO2000056361A2 Vaccine composition
09/28/2000WO2000056360A2 Vaccine against antigens from bacteriae
09/28/2000WO2000056359A2 Vaccine against streptococcus pneumoniae
09/28/2000WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
09/28/2000WO2000056357A2 Staphylococcus antigen and vaccine
09/28/2000WO2000056353A2 A uro-genital condition treatment system
09/28/2000WO2000056346A1 Stable oil-in-glycerin emulsion
09/28/2000WO2000056343A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/28/2000WO2000056341A1 Chemical compounds and their uses
09/28/2000WO2000056333A1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance
09/28/2000WO2000056331A1 Inhibitors of impdh enzyme
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000056303A2 Treatment of immune diseases
09/28/2000WO2000056282A1 Particle based vaccine composition
09/28/2000WO2000044727B1 Inhibitors for the biosynthesis of vitamin b2 and method for producing same
09/28/2000WO2000033822A9 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
09/28/2000WO2000023592A9 Minimal promoters and uses thereof
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO1999067417A3 Fitness assay and associated methods
09/28/2000DE19913692A1 Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen Mechanically stable pharmaceutical dosage forms containing liquid or semisolid surface-active substances
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2368026A1 Oxazole and thiazole combinatorial libraries
09/28/2000CA2368009A1 Use of non-nucleoside reverse transcriptase inhibitor (mni) for the treatment of hiv infection
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367471A1 Fungal beta-tubulin genes
09/28/2000CA2367266A1 Gel-microemulsion formulations
09/28/2000CA2367262A1 Treatment of immune diseases
09/28/2000CA2367118A1 A uro-genital condition treatment system
09/28/2000CA2366908A1 Vaccine composition
09/28/2000CA2366877A1 Chemical compounds and their uses
09/28/2000CA2366869A1 Use of trehalose for stabilising a liquid vaccine
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366613A1 Particle based vaccine composition
09/28/2000CA2366555A1 Method for detecting predisposition to a venous thromboembolic disease
09/28/2000CA2366152A1 Streptococcus pneumoniae vaccine
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365296A1 Vaccine
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365081A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
09/27/2000EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae
09/27/2000EP1038952A2 Processes for preparation of Marek's Disease Virus using continuous avian cell lines
1 ... 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 ... 1798